GavisconRegular Strength (GlaxoSmithKline Consumer Healthcare LP)
Welcome to the PulseAid listing for the Gaviscon drug offered from GlaxoSmithKline Consumer Healthcare LP. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | GlaxoSmithKline Consumer Healthcare LP |
| NON-PROPRIETARY NAME: | aluminum hydroxide and magnesium trisilicate |
| SUBSTANCE NAME: | ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, CHEWABLE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-06-13 |
| END MARKETING DATE: | 0000-00-00 |
Gaviscon Regular Strength HUMAN OTC DRUG Details:
| Item Description | Gaviscon Regular Strength from GlaxoSmithKline Consumer Healthcare LP |
| LABELER NAME: | GlaxoSmithKline Consumer Healthcare LP |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 80; 14.2(mg/1; mg/1) |
| START MARKETING DATE: | 2011-06-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0135-0096_a6624502-a0b5-464c-a149-f29189b41276 |
| PRODUCT NDC: | 0135-0096 |
| APPLICATION NUMBER: | NDA018685 |
Other ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE Pharmaceutical Manufacturers / Labelers:
